Answers are grounded in this paper and cite their sources.
studies confirmed the inhibitory effect of NSC777201 on TMEM2 expression, reinforcing its role in targeting PAAD. Therefore, TMEM2 has been identified as a theragnostic biomarker in PAAD, influenced by CAF activity and HA accumulation. NSC777201 exhibits significant potential in targeting and potentially reversing critical processes in PAAD progression, demonstrating its efficacy as a promising therapeutic agent.
No takes yet. Share an insight, caveat, or question.
Prateeti Srivastava (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: